JP:4597Dividends

Market cap
¥7B
P/E ratio
Develops and commercializes innovative cancer medicines across Asian markets including Japan, China, and South Korea, focusing on treatments and supportive care.

Latest Dividend per Share Forecast

0.00JPY

If you buy 100 shares of , the expected annual dividend is 0 JPY.

Dividend Yield
-
Payout Ratio
0.0%

Dividend Policy

<p>Our basic policy treats shareholder returns through capital gains via increased corporate value and dividend payments as important management initiatives. Currently, we prioritize advance investments and do not pay dividends. When our medicines under development are commercialized, we will consider implementing dividends while emphasizing a balance between development investments and shareholder returns. The record date for year-end dividends is December 31, and for interim dividends is June 30. Dividends are determined by Board of Directors resolution.</p>

Dividend per Share

Payout Ratio

Dividend Yield

Subscribe to premium to access
Dividend Yield.

Check pricing

Dividend History (Forecasts, Revisions, Actuals)

Fiscal YearTypeInterimYear-EndTotalPayout Ratio
FY2026Forecast(2026/02/13)000-
FY2025Actual(2026/02/13)000-
Forecast(2025/02/12)000-
FY2024Actual(2025/02/12)000-
Forecast(2024/05/15)000-
FY2023Actual(2024/05/15)000-
Forecast(2023/05/15)000-
FY2022Actual(2023/05/15)000-
Forecast(2022/02/09)000-
FY2021Actual(2022/02/09)000-
Forecast(2021/02/10)0000.0%
FY2020Actual(2021/02/10)0000.0%
Forecast(2020/11/13)00--
FY2019Actual(2020/11/13)00--